CHARLOTTESVILLE, Va. & ARLINGTON HEIGHTS, Ill.--(BUSINESS WIRE)--DiaKine Therapeutics, Inc. and AdPharma, Inc. today announced an agreement to develop a pipeline of drugs aimed at reversing diabetes. The first drug in the pipeline is Lisofylline (LSF), an immune modulating compound that has reversed type 1 diabetes in mice in combination with another agent.
